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The Pi concentration of mammalian cerebrospinal fluid (CSF) is about
one-half that of plasma, a phenomenon also shown here in the spiny
dogfish, Squalus acanthias. The objective of the present study was to
characterize the possible role of the choroid plexus (CP) in determin-
ing CSF Pi concentration. The large sheet-like fourth CP of the shark
was mounted in Ussing chambers where unidirectional 33Pi fluxes
revealed potent active transport from CSF to the blood side under
short-circuited conditions. The flux ratio was 8:1 with an average
transepithelial resistance of 87  17.9 ·cm2 and electrical potential
difference of 0.9  0.17 mV (CSF side positive). Active Pi absorp-
tion from CSF was inhibited by 10 mM arsenate, 0.2 mM ouabain,
Na-free medium, and increasing the K concentration from 5 to 100
mM. Li stimulated transport twofold compared with Na-free me-
dium. Phosphonoformic acid (1 mM) had no effect on active Pi
transport. RT-PCR revealed both Pi transporter (PiT)1 and PiT2
(SLC20 family) gene expression, but no Na-Pi cotransporter II
(SLC34 family) expression, in the shark CP. PiT2 immunoreactivity
was shown by immunoblot analysis and localized by immunohisto-
chemistry in (or near) the CP apical microvillar membranes of both
the shark and rat. PiT1 appeared to be localized primarily to vascular
endothelial cells. Taken together, these data indicate that the CP
actively removes Pi from CSF. This process has transport properties
consistent with a PiT2, Na-dependent transporter that is located in
the apical region of the CP epithelium.
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THE INORGANIC PHOSPHATE CONCENTRATION ([Pi]) in human ven-
tricular cerebrospinal fluid (CSF) ([Pi]CSF) is maintained at
0.4 mM compared with plasma at 1.8 mM (11, 16). How
and why [Pi]CSF is controlled at this lower concentration is
unknown. Despite the importance of [Pi] for the control of
normal cellular metabolic activity, extracellular and intracellu-
lar pH and [Ca2] (8), characterization of Pi transport by the
choroid plexus (CP) seems not to have been done in any
vertebrate. The CP forms 70–80% of the CSF and helps
stabilize and regulate its composition. The blood-brain barrier
(BBB) and metabolic water (20) are the apparent sources of the
remaining 20–30% of CSF. In addition to its buoying (cush-
ioning) effect, CSF provides a buffer for brain tissues against
variations in plasma composition (4). Specific epithelial trans-
port processes selectively mediate the exchange of various
substrates between plasma and brain interstitial fluid (ISF) and
CSF. Together, BBB and CP membrane transporters can per-
form a multitude of functions including the removal of organic
wastes from brain ISF and CSF while actively managing the
inorganic ion composition and rate of formation of these fluids.
CSF is 15 meq higher in Cl than plasma with only about
one-half the plasma [K]. [Na] and pH are about the same as
plasma, and [HCO3] in CSF ([HCO3]CSF) can vary but is
usually similar to or less than that of plasma (4).
The mechanism of regulation of [Pi]CSF is unclear. Several
factors leading to significant changes in [HCO3]CSF and [Cl]
in CSF evoked modifications in [Pi]CSF (15, 16). Whether these
reflect direct or indirect effects over specific Pi transport
mechanisms was not established. The existence of a Pi/HCO3
exchange process in isolated BBB capillaries has been sug-
gested (5, 6). ISF enters CSF by slow bulk flow and most likely
travels along perivascular pathways and axon tracts. CSF may
circulate and mix with ISF along these same pathways (1).
Therefore, the BBB could, at least in part, contribute to the Pi
balance in CSF. However, these studies were not further
explored, and the existence and possible relevance of such
transporters have not been demonstrated in the CP. While we
lack a detailed understanding of the mechanisms that mediate
and modulate the establishment and maintenance of [Pi]CSF,
our understanding of the major processes influencing plasma
[Pi] are fairly well understood and have been reviewed (see
Ref. 36). To summarize, in the intestine and kidney, members
of the Na-Pi cotransporter type II (NaPiII) family (SLC34),
located in the apical membrane of enterocytes and the proximal
tubule epithelium, are well-characterized carriers responsible
for Pi entry into epithelial cells (SLC34b for intestinal absorp-
tion and SLC34a and, to a lesser extent, SLC34c for renal
reabsorption). Two other Na-Pi cotransporter types are
known: type III (SLC20) and type I (SLC17). The latter has a
low specificity for Pi transport and rather more for organic
anions, including glutamate. The two SLC20 family members,
Pi transporter (PiT)1 (SLC20A1) and PiT2 (SLC20A2), are
ubiquitously expressed and thought to have mainly a cellular Pi
housekeeping role, but other more specific roles are emerging
for these transporters.
Direct determination of the cellular mechanisms that medi-
ate transepithelial transport of Pi and other solutes across the
intact mammalian blood-CSF barrier is limited by the tissue’s
complex morphology, relatively small size, and limited acces-
sibility. The frond-like folds of the mammalian CP prevent
direct access to the basolateral membranes of the epithelium
with techniques relying on ventriculocisternal perfusion or an
isolated, intact CP. In the dogfish shark, Squalus acanthias, the
fourth ventricle of the brain is covered by a sheet of choroidal
epithelium with shallow convolutions, which, unlike the highly
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enfolded CP of mammals, lies on the surface of the brain and
can be removed and mounted in Ussing chambers. The dogfish
CP tissue is also 25-fold larger than that of humans (as a
percentage of brain weight) and has proven to be an effective
means of modeling this tissue’s transepithelial transport prop-
erties (25, 34, 35).
Here, we report that spiny dogfish shark [Pi]CSF is main-
tained below that of plasma, as in humans, and that this is
likely due to a powerful Pi transport system in the CP, active in
the CSF-to-blood direction, and with PiT (Slc20)-like transport
properties. We found no evidence of Slc34 (NaPiII family of Pi
transporters) expression in the shark CP; however, both PiT1
and PiT2 were expressed there. PiT1 appears to be located
mainly in the vascular endothelium, whereas PiT2 is localized
in, or in close proximity to, the apical microvillar membranes
of the CP epithelium at the ventricular surface in both the shark
and rat.
MATERIALS AND METHODS
Animals. Adult male and female spiny dogfish sharks (S. acanthias
L., 2-kg body mass) were collected from the coastal waters off
Woods Hole, MA, by the Marine Biological Laboratory or off Mount
Desert Island, ME, and transported to Mount Desert Island Biological
Laboratory, where they were held in large (12,000 liter) tanks of
flowing seawater for 5–10 days before use. Experiments were con-
ducted in the period from mid-July to mid-September, during which
tank temperature ranged from 13 to 17°C. Animals were decapitated,
and the cranial compartment was immediately removed, flooded with
ice-cold elasmobranch Ringer (ER) solution (see below and Table 1),
and placed on ice. The brain was removed, and, while the brain was
submerged in ice-cold sterile ER solution, the two halves of the fourth
plexus were excised and cleared of extraneous tissue. Tissues were
then prepared for immunoblot analysis, immunohistochemistry, or
RNA extraction or mounted in Ussing chambers for measurements of
transepithelial transport.
The mammalian lateral CP was removed from albino laboratory
rats (Rattus norveigicus), which were anesthetized with isoflurane and
decapitated within 10 min postmortem. The present study adhered to
the “Guiding Principles for Research” as outlined by the American
Physiological Society (2002). All investigations involving animals
reported in this study were conducted in conformity with these
principles. The animal protocol for sharks was approved by the
Institutional Animal Care and Use Committee of Mount Desert Island
Biological Laboratory (protocol no. 0606, MDIBL Institutional As-
surance no. A3562-01), and the protocol for rats was approved by the
Institutional Animal Care and Use Committee of the University of
Connecticut (no. A11 038R).
Solutions and chemicals. ER solutions in original and modified
forms [Na-free ER, Li-containing ER (Li-ER), and high-K ER
solutions] were prepared according to the specifications shown in
Table 1. Saline solutions were prepared in advance and kept at 4°C,
and labile substances such as urea, trimethylamine N-oxide, and
glucose were added to the working volume just before use. For
treatment with sodium arsenate (10 mM), phosphonoformic acid
(PFA; 1 mM), or ouabain (0.2 mM), working solutions were prepared
fresh each day. The protein-free nature of the ER solution closely
resembled artificial elasmobranch CSF (12) and, consistent with a
short-circuited state, was used on both sides of the tissue during
transport measurements.
Plasma and CSF ionic composition. Blood samples were collected
from the caudal vein and placed at 4°C until completely clotted, at
which time serum was removed to a fresh tube. After animals had
been decapitated, CSF was collected from the cranial cavity with a
1-ml syringe fitted with a blunted pipette tip. Both fluids were either
immediately analyzed or frozen for later evaluation of cation and
anion composition. [Na], [K], [Mg2], [Ca2], [Cl], [Pi], and
[SO42] were determined using a Dionex DX-120 ion chromatograph.
Transepithelial Pi transport. Excised halves of the fourth CP were
mounted in Ussing chambers with an aperture size of 0.197 cm2 and
fluid volume (ER solution) of 1.9 ml/hemichamber. The temperature
was maintained at a constant 14°C, and fluid inside the chambers was
constantly and vigorously stirred with small magnetic stir bars turned
by external stir plates and insufflated with humidified 99% O2-1%
CO2. The transepithelial potential difference (TPD) was determined
with Ag/AgCl electrodes connected to the CSF and interstitial (blood
side) compartments with 3 M KCl-2% agar bridges. Electrical prop-
erties were determined with a computer-controlled, high-impedance
automatic dual-voltage clamp (DVC 4000, World Precision Instru-
ments, Sarasota, FL). Electrode asymmetry was corrected at the
beginning and end of each experiment. Short-circuiting electrodes
were connected to the CSF and interstitial solutions with 3 M KCl-2%
agar bridges. The transepithelial resistance (TER) was determined
from the change in TPD produced by a brief 10-A pulse controlled
by the voltage clamps. TER was corrected for fluid resistance. During
flux determinations, the tissues were continuously short circuited (i.e.,
clamped at TPD 0 mV), and the integrity of the tissues was assessed
by measurements of TPD and TER at various time points during and
at the end of each experiment.
Unidirectional tracer fluxes were initiated by the addition of 1.0
Ci H333PO4 (MP Biomedicals) to the appropriate hemichamber.
Duplicate 50-l samples were taken from the unlabeled side at 30-min
intervals over a period of 2 h and replaced with equal volumes of
unlabeled solution. Radioactivity was measured by liquid scintillation
(Packard TriCarb 2200CA). The specific activity of the labeled
solution was determined at the beginning and end of each experiment.
Net flux was calculated as the difference between unidirectional
secretory (blood side to CSF side) and reabsorptive (CSF side to blood
side) fluxes.
To determine the effects of arsenate, PFA, or ouabain on active Pi
transport, tissues in Ussing chambers were initially incubated in ER
solution (with H333PO4 added to the CSF side) for 60 min to establish
basal transport, and this solution was then removed and replaced with
ER solution containing the appropriate inhibitor at the described
concentrations. Isotope was added to the CSF side, and transport was
measured for 60 min. To establish the roles of Na and Li, transport
Table 1. Composition of the saline solutions used for
measurements of transepithelial transport
ER Solutions
Regular ER
solution
Na-free ER
solution
Li-containing
ER solution
High-K ER
solution
NaCl 280 180
LiCl 280
KCl 6 4 4 106
CaCl2 4 4 4 4
MgCl2 3 3 2.5 3
NaH2PO4 1 1
K2HPO4 1 1
NaHCO3 8 8
Na2SO4 0.5 0.5
MgSO4 0.5 0.5
N-methyl-D-glucamine
titrated with HCl 280
Trimethylamine
N-oxide 72 72 72 72
Urea 350 350 350 350
HEPES 25 25 25 25
Glucose 5 5 5 5
pH adjusted to 7.8 7.8 7.8 7.8
Values are in mM. ER solution, elasmobranch Ringer solution.
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was initially measured in Na-free ER solution for 60 min; the tissue
was then rinsed, and Li-ER solution was added for 60 min followed
by a rinse and the addition of normal Na-containing ER solution for
an additional 60 min. To determine the effects of changing the plasma
membrane K gradient, transport was measured in control ER solu-
tion for 60 min, and the solution was then replaced with high-K ER
solution for an additional 60-min measurement. To establish whether
this effect was reversible, some tissues were then returned to control
ER solution for an additional 60-min flux measurement. Control flux
measurements were done by changing solutions as described above
using only control ER solution.
Isolation of mRNA and RT-PCR. Freshly isolated tissues were
collected into RNAlater (Sigma) and stored at 4°C until further
processed. RNA was isolated from tissues using the Qiagen RNeasy
kit according to the manufacturer’s instructions. RNA concentrations
and purity were measured at 260 and 280 nm using a UV Nanodrop
spectrophotometer (Thermo Scientific) to ensure the same total RNA
from each tissue per reaction. Synthesis of cDNA and semiquantita-
tive PCR were performed using the Qiagen OneStep RT-PCR kit, and
primers were generated (Integrated DNA Technologies) against the
partial sequences for spiny dogfish shark NaPiII, PiT1, and PiT2
retrieved from MDIBL expressed sequence tags (for primer sequences
and respective GenBank Accession Numbers, see Table 2). The RT
reaction was performed at 50°C for 30 min followed by 95°C
incubation for 15 min to denature the reverse transcriptase. This was
immediately followed by the PCR, which had a denaturing tempera-
ture of 94°C for 1 min, an annealing temperature of 54°C for 1 min,
and an extending temperature of 72°C for 1 min for 30 cycles.
Identical amounts of PCR products were separated on a 1% agarose
gel and stained with Gel-Star (Lonza Rockland, Rockland, ME).
Immunolocalization. Immunohistochemistry of PiT1 and PiT2 was
done with polyclonal rabbit anti-human antibodies (PiT1: sc-98814,
Santa Cruz Biotechnology; PiT2: HPA026540, Sigma-Aldrich) di-
luted 1:1,600 and 1:1,000, respectively. Shark fourth CPs were fixed
in 10% formalin and paraffin embedded. Five-micrometer sections
were quenched with 3% H2O2 for 10 min (PiT2) or 30 min (PiT1).
Antigen retrieval for PiT2 was done with Target Retrieval Solution
(Dako) for 20 min in steam. PiT1 antigen retrieval was done by
treatment with Dako’s Proteinase K solution for 10 min. After
blockade with Animal-Free Block solution (Vector), primary antibody
exposure was done for 60 min (PiT2) or overnight (PiT1). In all cases,
the secondary antibody was Dako’s Envision  Dual Link Polymer
(catalog. no. K4063) exposure for 30 min. Chromogen was nova red
(SK-4800, Vector) applied for 10 min and counterstained with hema-
toxylin. Isotype controls were treated with nonimmune rabbit IgG
instead of primary antibody.
Immunohistochemistry of PiT2 in the rat lateral CP was done with
a goat anti-human antibody (sc-50274, Santa Cruz Biothechnology)
and fivefold excess blocking peptide (sc-50274P, Santa Cruz Bioth-
echnology). Rat tissues were prepared for immunohistochemistry as
described above.
Protein isolation, SDS-PAGE, and immunoblot analysis. CPs were
placed in sample buffer (2.3% SDS, 5% 	-mercaptoethanol, 10%
glycerol, 0.5% bromophenol blue, and 62.5 mM Tris·HCl, pH 6.8)
containing a mixture of protease inhibitors, vortexed vigorously, and
centrifuged. The supernatant was collected and used for SDS-PAGE
(12% resolving gel, 4% stacking gel). Gel products were transferred to
a polyvinylidene fluoride (PVDF) membrane (Millipore). PVDF
membranes were treated with blocking buffer (PBS containing 137
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, and 1.5 mM KH2PO4, pH
7.3 with HCl) with 3% nonfat dry milk and 0.05% Tween 20 for 2 h
at room temperature. Spiny dogfish shark PiT2 was detected using an
affinity-purified polyclonal rabbit anti-rat antibody (kindly provided
by Dr. Victor Sorribas, University of Zaragoza, Zaragoza, Spain)
diluted 1:500 and a rabbit anti-human polyclonal antibody (SLC20A2,
HPA026540, Sigma-Aldrich) diluted 1:500. Rat lateral CP PiT2 was
detected with the antibody provided by Dr. Sorribas as described
above and with a commercially available goat anti-human antibody
(sc-50274 and blocking peptide sc-50274P, Santa Cruz Biotechnol-
ogy) diluted 1:500. 	-Actin was detected with a commercially avail-
able affinity-purified polyclonal rabbit anti-	-actin antibody diluted
1:1,000 (Sigma) (30). PVDF membranes were incubated in the PBS-
dry milk-Tween 20 solution containing the primary antibodies at 4°C
for 1 h (	-actin) or overnight (PiT2), washed three times for 10 min
in the PBS-dry milk-Tween 20 solution, and incubated with secondary
goat anti-rabbit (Sigma) or donkey anti-goat (Santa Cruz, sc2020) IgG
peroxidase conjugate diluted 1:2,000 and 1:5,000, respectively, in the
PBS-dry milk-Tween 20 solution for 1 h at room temperature. Mem-
branes were washed three times for 10 min in the PBS-dry milk-
Tween 20 solution and then rinsed twice with PBS. Signals were
detected using ECL Western blotting reagents (Pierce) according
to the manufacturer’s instructions and developed on X-ray film
(Fujifilm).
Statistics. Experimental results are expressed as means  SE of
4–7 individual tissues or fluid samples. To determine differences
between the composition of plasma and CSF, a Student’s t-test was
used. For comparison between two sets of data showing transport
function, the hypothesis that two values recorded in the same tissue at
60 min after exposure to each treatment were identical was tested
using a paired t-test. The same method was used for the analysis of
TER data. Values were considered different at a 95% confidence
level. Statistical analyses were done using SigmaStat 3.0 (SYSTAT
Software).
RESULTS
Plasma and CSF composition. The concentrations of several
inorganic components of shark serum and CSF are shown in
Table 3. CSF taken from the fourth ventricle and serum from
the caudal hemal vein blood was no different in cation or
sulfate concentrations. Very significant differences in the two
fluids were apparent in [Cl] and [Pi]. As in mammals, [Cl]
was 15 mM higher in CSF, and [Pi]CSF was about one-half
that of serum.
Table 2. Primer sequences used for the amplification of NaPiII, PiT1, and PiT2 from dogfish shark tissues
Sequence GenBankAccession Number(s) Band Size, bp
NaPiIIb1/2
Forward: NaPi2-b12_Fw1 5=-GATTKCTTYAATTGGCTC-3= AF297181 and AJ297182 566
Reverse: NaPi2-b12_Rv1 5=-TATSGGAAATCRGTGTTA-3=
PiT1
Forward: PiT1_Fw1 5=-ACTCCCGAGGATGAAGGT-3= CX197599 and EE889121 334
Reverse: PiT1_Rv1 5=-TGCCCATTGTCTGAATAACT-3=
PiT2
Forward: PiT2_Fw2 5=-ATAACCTAAGCCTAAGAAAC-3= DV496363 381
Reverse: PiT2_Rv2 5=-AATGGAAGCCAGGATACA-3=
NaPiII, Na-Pi cotransporter II; PiT, Pi transporter.
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Unidirectional Pi fluxes. With transepithelial voltage (0.9 
0.17 mV, sign refers to the ventricular side) clamped at zero
and identical ER solution on each side, 33P-labeled Pi unidi-
rectional fluxes across the freshly dissected dogfish shark
fourth CP were measured. The summary of a few time courses
(Fig. 1) showed that while transepithelial transport in the
blood-to-CSF direction was low and rather homogeneous,
CSF-to-blood fluxes were much greater and somewhat more
variable between preparations from individual animals. In most
preparations, steady-state Pi flux was achieved within 30 min
after the addition of 33Pi, and, although typical experiments
lasted only 2 h, the tissues maintained stable transport rates for
at least 4 h (data not shown). The magnitude of the fluxes in the
CSF-to-blood direction averaged approximately eight times
that measured in the opposite direction, but, in some cases, flux
ratios of up to 30:1 were observed. The two halves of the same
fourth CP generally had very similar TER; however, prepara-
tions from different individuals varied somewhat more (86.6
17.9 ·cm2 for the tissues shown in Fig. 1).
The transport properties of the prominent members of Slc34
and Slc20 in the gut and renal tubule have been determined in
heterologous expression systems (see Ref. 36). Three members
of the Slc34 family, NaPiIIa and NaPiIIc in the renal proximal
tubule and NaPiIIb in the duodenum and jejunum, together
with two members of the Slc20 family, PiT1 and PiT2, have
been compared. These reported functional properties were used
here to partially characterize the CP active Pi transport process.
Effects of arsenate and PFA. Incubation of tissues with the
Pi mimetic arsenate (10 mM) for 60 min clearly reduced Pi
transport across the CP (Fig. 2A). Fluxes were reduced from
49.9  3.10 to 10.9  1.11 nmol·h1·cm2, roughly a fivefold
reduction, but no significant change was observed in TER
(71.0  4.77 and 66.3  5.45 ·cm2 for control and arsenate-
treated periods, respectively). Treatment with PFA, however,
had no significant effect on Pi transport (Fig. 2B) or TER.
During the control and PFA treatment periods, mean fluxes and
TER were 35.5  13.21 nmol·h1·cm2 and 77.4  13.91
·cm2 and 45.5  14.96 nmol·h1·cm2 and 79.0  13.54
·cm2, respectively. In our laboratory, 1 mM PFA strongly
inhibited Pi uptake by mouse renal proximal tubule primary
cultures (30) (56.4  1.73% of control, n  3), confirming the
observations of others on the effectiveness of PFA in a tissue
where NaPiIIa transport predominates.
Na/Li-dependent Pi transport. Treatment of tissues with
0.2 mM ouabain induced a 1.5-fold reduction in Pi flux (Fig.
2C), but the Na-K-ATPase inhibitor had no effect on tissue
TER, which was 77.0  14.64 ·cm2 after 60 min in regular
ER solution and 80.6  16.94 ·cm2 after 60 min in ER
solution containing ouabain. In another set of tissues, substi-
tution of regular ER solution with Na-free ER solution
greatly reduced Pi transport from CSF to the blood side (Fig.
2D). In this series of measurements, average Pi transport in
Na-free ER solution (6.8  2.82 nmol·h1·cm2) was
roughly 4.5-fold lower than in regular ER solution (29.7 
4.12 nmol·h1·cm2), which was accompanied by significantly
different (P 
 0.004) TER, with recorded mean values of
56.4  5.70 and 126.6  17.56 ·cm2 for ER and Na-free
ER solutions, respectively.
Substitution of Li for all of the N-methyl-D-glucamine in
Na-free ER solution (Li-ER solution) induced a significant
2.5-fold increase in Pi transport by tissues previously incubated
in Na-free ER solution (from 3.9  1.11 to 9.7  2.18
nmol·h1·cm2). When Li-ER solution was replaced with
regular Na-containing ER solution, the Pi flux further in-
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Fig. 1. Representative data showing the unidirectional [secretory: blood (BL)
to cerebrospinal fluid (CSF) and reabsorptive: CSF to BL] transport (solid
triangles) and net transepithelial transport (gray circles) of radiolabeled Pi by
the shark fourth (IVth) choroid plexus (CP) mounted in Ussing chambers and
short circuited, i.e., elasmobranch Ringer (ER) solution was on both sides, and
transepithelial potential difference was clamped at zero. 33Pi was added at time
0, and steady-state flux was usually reached within 30–60 min. Data points are
means  SE; n  4.
Table 3. Comparison of the ionic composition of serum and
cerebrospinal fluid in the spiny dogfish
Component Serum Cerebrospinal Fluid
Major cations
Sodium 270 3.8 275  4.5
Potassium 2.7 0.36 2.7  0.10
Magnesium 1.4 0.15 1.6  0.13
Calcium 5.2 0.17 5.2  0.12
Major anions
Chloride 240 5.2 254  2.9†
Phosphate 1.3 0.33 0.6  0.11*
Sulfate 0.5 0.20 0.4  0.16
Values (in mM) are means  SE; n  6–8. Significant differences from
serum at *P  0.05 and †P  0.001, respectively.
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creased to 20.5  7.06 nmol·h1·cm2, more than twice that
observed in Li-ER solution and about five times higher than
in Na-free ER solution (Fig. 2E). TERs in these tissues
averaged 139.9  19.74 ·cm2 in Na-free ER solution,
93.0  20.34 ·cm2 in Li-ER solution, and 70.8  20.50
·cm2 in regular ER solution. The differences among treat-
ments were all statistically significant on a paired basis (P 
0.001).
K gradient dependence. Substitution of ER solution with
K-rich ER solution (100 mM K) resulted in an approxi-
mately threefold decrease in the Pi transport rate (Fig. 2F). These
changes (from 60.7 7.77 to 22.5 3.05 nmol·h1·cm2) were
not caused by changes in TER, which averaged 48.7  3.35 and
43.0  3.42 ·cm2 for ER and K-rich ER solutions, respec-
tively. In experiments aimed to evaluate the reversibility of this
effect, when K-rich ER solution was removed and tissues were
incubated with regular ER solution again for an additional 60 min,
the Pi flux recovered to the initial level (see Fig. 2F, inset). K
was increased by substituting 100 mM K for 100 mM Na, and
it should be noted that the remaining Na of 180 mM is well
above the saturating concentration for mammalian PiT2 expressed
in Xenopus oocytes (26).
Pi transporter expression and localization. Data “mining” of
the MDIBL S. acanthias expressed sequence tag database
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Fig. 2. Effects of two classical inhibitors of Pi
transport and treatments altering Na and K
plasma membrane gradients on net transepi-
thelial transport across the isolated shark
IVth CP. A: tissues were exposed (on both
CSF and BL sides) to standard ER solution
for 60 min and then to the same solution
containing sodium arsenate for another 60
min (n  6). B: in a similar experiment,
tissues initially exposed to ER solution for 60
min were subsequently treated with 1 mM
phosphonoformic acid (PFA; n  6). C: tis-
sues were exposed (on both CSF and BL
sides) to standard Na-containing ER solu-
tion for 60 min with a subsequent exposure to
the same solution containing 0.2 mM ouabain
(n  6). D: tissues were bathed in Na-
containing ER solution for 60 min followed
by an exposure to Na-free ER solution for
60 min (n 6). E: Pi transport by the isolated
shark IVth CP exposed (on both CSF and BL
sides) to Na-free ER soltuion (with 280 mM
N-methyl-D-glucamine) for 60 min, to Li-
containing ER solution (280 mM LiCl) for 60
min, and then to standard Na-containing ER
solution (280 mM NaCl) for another 60 min
(n  5). F: the shark IVth CP was exposed
(on both CSF and BL sides) to standard ER
solution for 60 min and then to K-enriched
ER solution (100 mM KCl substituted for
100 mM NaCl) for another 60 min (n  7).
Inset: plot demonstrating that the tissue trans-
port capability was not permanently compro-
mised by high K (n  4). *Significantly
different from control (P  0.01). Data are
means  SE. Solid circles connected by
dotted lines show changes in transport rates
for individual preparations before and after
exposure to the respective solution.
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(DeCypher.MDIBL.org) identified several partial DNA se-
quences that showed considerable conservation with zebrafish
(Danio rerio, NP_997753, NP_998344 and NP_001071014),
green pufferfish (Tetraodon negroviridis, CAG08601), African
clawed frogs (Xenopus laevis, NP_001083287 and NP_
001088186), rats (R. norvegicus, NP_112410 and NP_058919), and
humans (Homo sapiens, NP_005406 and NP_006740.1) PiT1 and
PiT2 proteins. Two of these sequences corresponded to 76
(PiT1) and 100 (PiT2) amino acids in a very conserved region
near the NH2-terminus, encompassing the extracellular domain
and first and second transmembrane domains, the first (intra-
cellular) loop and extending into part of the second (extracel-
lular) loop (PiT1), and the third transmembrane domain (PiT2).
These sequences shared 72% nucleotide and 82% protein
identity and cluster differently with PiT1 and PiT2. A third
fragment was found with a high correspondence to a 232-
amino acid region that spans from approximately half of the
seventh loop (intracellular) to the tenth loop (extracellular),
thus comprising transmembrane domains seven, eight, and
nine. This sequence shared considerably higher identity with
the amino acid sequence of PiT1 than of PiT2 in X. laevis (72%
vs. 60%), R. norvegicus (84% vs. 59%), and H. sapiens (86%
vs. 59%).
Partial DNA sequences for S. acanthias NaPiIIb (Slc34A2)
can be found in the GenBank database, named as NaPiIIb1 and
NaPiIIb2. These correspond to protein fragments of 230 and
290 amino acids, spanning from the end of the fourth to the
beginning of the tenth transmembrane domains. The dogfish
NaPiIIb1 fragment shares 66% identity with NaPiIIb2 and 59%
with rat NaPiIIa (Slc34A1) and 68% with rat NaPiIIb equiva-
lent regions, whereas the dogfish NaPiIIb2 fragment shares
65% identity with rat NaPiIIa and 66% with rat NaPiIIb.
Electrophoresis of RT-PCR products obtained using PiT1-
or PiT2-specific primers (Table 2) showed bands of the ex-
pected size in the shark fourth CP as well as in the shark kidney
(used as a positive control tissue; Fig. 3). For the RT-PCR
performed using degenerate primers for NaPiII (these were
designed for regions with high homology between the Na-
PiIIb1 and NaPiIIb2 shark sequences to detect the presence of
either or both mRNA types), no bands appeared in lanes
corresponding to the CP, but bands of the expected size were
present for products obtained with shark kidney cDNA.
Immunohistochemical analyses of PiT1 and PiT2 in the
shark fourth CP are shown in Fig. 4. The presence of nucleated
red blood cells in the vascular spaces helped to locate endo-
thelial cells, which have flattened nuclei compared with the CP
epithelium (Fig. 4A). Immunostaining revealed that PiT1 was
located predominantly in vascular endothelial cells, although a
weak signal may be in the basolateral membranes of the CP
epithelium (Fig. 4C). There was no indication of PiT1 in the
microvilli of the ventricular surface. The PiT1 subcellular
location within the highly attenuated endothelial cells was not
resolvable.
PiT2 immunostaining revealed a very clear localization of
PiT2 in the shark CP epithelium (Fig. 4D). The strongest PiT2
signal was in the microvilli of the ventricular surface, although
weak staining in the basolateral membranes and cytosol could
not be ruled out. There was no indication of PiT2 staining in
any other part of the CP. Localization of PiT2 immunostaining
was the same in the rat lateral CP as in the shark CP (Fig. 5).
Staining in the apical microvilli (Fig. 5A) was absent in the
presence of the blocking peptide (Fig. 5D).
Shark and rat lateral CP and shark fourth CP immunoblots
are shown in Fig. 6. Lanes 1 and 2 show that anti-human and
anti-rat PiT2 antibodies worked equally well to reveal a distinct
single band at 72 kDa in the shark fourth CP, which corre-
sponds to the expected mass based on the amino acid sequence
for rat PiT2. Lanes 2 and 3 show that the shark fourth CP and
shark lateral CP had the same PiT2 signal. Lanes 4 and 5 show
that the anti-rat PiT2 antibody worked equally well in shark
and rat CPs. Lanes 6 and 7 confirmed the effectiveness of the
blocking peptide used for immunolocalization of the PiT2
signal in the rat CP shown in Fig. 5. The presence of a band
corresponding to 	-actin (of 42 kDa) was also identified in
these samples and used as a relative internal standard to control
for the integrity of the protein extracts.
DISCUSSION
[Pi]CSF of the dogfish shark was consistently lower than that
of serum, and [Cl] in CSF was higher than in serum. These
characteristics are also normal in mammals, including humans
(4, 16). The values reported here for the inorganic ion concen-
trations in spiny dogfish CSF are in agreement with previously
reported measurements (12); however, this seems to be the first
determination of [Pi] and [SO42] in S. acanthias CSF. Con-
sidering the phylogenetic distance, the relationships between
the concentrations of Cl1 and phosphate in plasma and CSF
are apparently very highly conserved.
The potent active transepithelial transport process in the CP
described above likely participates in maintaining the lower
[Pi]CSF. The advantageous anatomic arrangement of the fourth
600
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100
IVth CP IVth CP IVth CPKd Kd Kd
PiT-1 PiT-2 NaPi-2
bp bp
Fig. 3. Gene expression of Pi transporter (PiT)1 and PiT2
(Slc20) and Na-Pi cotransporter type IIb [NaPiIIb (NaPi-2);
Slc34] in the spiny dogfish shark. A representative agarose gel
is shown loaded with equal amounts of RT-PCR products from
RNA extracted from the IVth shark CP and dogfish shark
kidney (Kd). There was no expression of NaPiIIb in the IVth
CP. No bands were detected when the reactions were run
without the RT step.
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ventricle and CP of the spiny dogfish shark as well as its
suitability for Ussing chamber work make the determination of
active Pi transport relatively certain. With the CP epithelia
chemically and electrically short circuited, the Pi flux ratios
were as high as 30:1. The in vitro transepithelial potential was
about1 mV, ventricular side positive, with identical, protein-
free ER solution on each side. This is consistent with the earlier
measurements of 2 to 4 mV also done in Ussing chambers
(23). The mammalian transepithelial potential determined in
vivo is also 2 to 7 mV, CSF side positive (14).
Several of the criteria we used to categorize the active Pi
transport process were based on heterologous expression sys-
tems for SLC20 and SLC34 gene families (36). The five
Pi transporters known to participate in Pi uptake by mammalian
tissues capable of transepithelial Pi transport are PiT1, PiT2,
NaPiIIa, NaPiIIb, and NaPiIIc. Distinctive features include the
following: 1) all are Na symporters and competitively inhib-
ited by arsenate; 2) PFA blocks NaPiII types much more
effectively than PiT types; 3) only NaPiIIc is electroneutral; 4)
Li, in the complete absence of Na (2), can drive transport on
the PiT types but not NaPiII types; and 5) PiT-type proteins
preferentially transport the monovalent form H2PO4, whereas
NaPiII type proteins all preferentially transport HPO42.
Arsenate is commonly used to inhibit Pi transport in
numerous assays (see Ref. 32) and, as a Pi analog, interacts
relatively effectively with NaPiIIa, NaPiIIb, and NaPiIIc as
well as with PiT1 and PiT2, but with much lower affinity
than Pi. Although TER was unchanged by arsenate treat-
ment, general metabolic effects may have contributed to the
inhibition of transport; nevertheless, the arsenate effect
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Fig. 4. Immunohistochemistry of paraffin-em-
bedded spiny dogfish shark CPs. A: hematox-
ylin and eosin stain. B: isotype for PiT1 and
PiT2 showing no nonspecific staining. C: PiT1
(1:1,600) showing light staining in the vas-
cular endothelium. D: PiT2 (1:1,000) showed
heavier staining localized to the apical mem-
brane region. CSF, ventricular location of
CSF; RBC, nucleated shark red blood cells;
MV, microvilli of apical surface; VS, intra-
vascular space. Scale bar  25 m.
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Fig. 5. Immunohistochemistry of parafifin-
embedded rat lateral CPs. A: hematoxylin and
eosin stain. B: isotype control for goat non-
immune IgG. C: rat lateral CP stained with
goat anti-human PiT2 antibody. D: rat lateral
CP stained with goat anti-human PiT2 anti-
body in the presence of blocking antigen.
Scale bar  25 m.
F1281INORGANIC PHOSPHATE TRANSPORT BY THE CHOROID PLEXUS
AJP-Renal Physiol • doi:10.1152/ajprenal.00458.2013 • www.ajprenal.org
Downloaded from www.physiology.org/journal/ajprenal (194.210.252.053) on April 4, 2019.
observed was consistent with facilitation of Pi transport by
specific transporters.
The active transepithelial transport reported here was dra-
matically, and reversibly, influenced by the cellular K gradi-
ent, consistent with a reversible plasma membrane depolariza-
tion and arguing against electroneutral transport (NaPiIIc-like).
The lack of effect of PFA at 1 mM on net Pi transport by the
CP is consistent with PiT-type transport and the fact that we
detected no NaPiII gene expression there. Phosphonocarboxy-
lic acids, including PFA, are effective inhibitors of Pi uptake by
renal brush-border membrane vesicles (26, 39), where NaPiII
transporters predominate; however, they have no effect on
PiT1 or PiT2 when these transporters are overexpressed in
oocytes (26) or in vascular smooth muscle cells at 1 mM and
inhibited only 47% even at 10 mM (31).
Early work showed no significant driving ability by a Li
gradient on NaPiII (3, 36), and although more recent work has
indicated that Li does appear to have a very low potential to
drive NaPiII phosphate transport, this cation interacts much
more readily with PiT types than with NaPiII types. Work on
rat vascular smooth muscle PiT1 and PiT2 has indicated that
Li will support5% of the PiT1 phosphate transport capacity
seen with normal [Na] and 12% of PiT2 transport (31). In
the present study, Li, in the complete absence of Na, drove
almost one-half of Na-dependent phosphate transport, adding
support for a significant role of PiT types in CP active Pi
transport.
The degenerate primers used for the detection of NaPiIIb
isoforms, the only known type II transporters in the shark, gave
no evidence that these genes were expressed in the CP even
though a strong signal was present in kidney samples. This
does not rule out the presence of type II transporters in the CP,
but it is consistent with the PiT-like transport data. Further-
more, immunolocalization indicated that PiT2 is appropriately
positioned in the tissue to move Pi in the CSF-to-blood direc-
tion. The extent of heterologous antibody specificity and un-
known tissue-specific antigenicity notwithstanding, there is a
high degree of sequence conservancy in PiT2 across phyla,
and, together with the PCR gene expression data, the present
findings strongly indicate that the molecular correlate of trans-
epithelial Pi transport by CP is PiT2.
It is possible that part of the control of [Pi]CSF may reside in
the BBB. An anion exchange process in the BBB (or associated
glia) may have an important contribution to the buffering
capacity of the extracellular compartment of the brain (24), and
studies (9, 10) on isolated BBB capillaries revealed a Pi/HCO3
exchange process. The influence of the BBB on [Pi] in ISF
could impact CSF through drainage of ISF across the ependy-
mal lining of the ventricles. A hypothetical model incorporat-
ing a possible source (BBB via the ISF) and exit pathway for
Pi is shown in Fig. 7.
The overall structure of the Pi-transporting motif in the
ubiquitously expressed SLC20 family has remained virtually
unchanged during evolution, leading to the idea that PiTs
generally fulfill housekeeping roles in cellular Pi homeostasis
(7). There is also evidence for specific functional roles in bone
mineralization and cell proliferation (PiT1) as well as [Pi]-
sensitive and pH-sensitive renal reabsorption (PiT2) (18). In-
terestingly, the modification of PiT2 caused by changing [Pi]
seems to be independent of its transport capability and suggests
an involvement in Pi sensing (29).
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Fig. 7. The tissues that form and define CSF are shown in this hypothetical
model of Pi entry and exit. Pi may enter interstitial fluid via the blood-brain
barrier in exchange for HCO3 (9). The interstitial fluid presumably mixes with
CSF by bulk flow through the ependymal lining of the ventricles, which
generally lack tight junctions, adding Pi to CSF. The CP epithelium is
hypothesized to use PiT2 in the apical microvilli to actively transport Pi into
the cell and then to the CP interstitium, by unknown processes, where it is
carried away by the highly fenestrated CP capillaries.
Fig. 6. A representative immunoblot of PiT2 in the dogfish IVth CP and lateral
CP and rat lateral CP. The single band at 70 kDa (top) was coincident with
the published PiT2 protein amino acid sequence in the rat. The lower band
(bottom) indicates the presence of 	-actin (42 kDa). Bands were made
visible using either goat anti-rabbit peroxidase-conjugated secondary antibody
(lanes 1–5) or donkey anti-goat peroxidase-conjugated secondary antibody
(lanes 6 and 7). Lane 1, shark IVth CP stained with rabbit anti-human
antibody HPA026540 (Sigma); lanes 2 and 3, shark IVth CP and shark lateral
CP, respectively, stained with rabbit anti-rat antibody (gift of Dr. Sorribas);
lanes 4 and 5, shark and rat lateral CPs, respectively, stained with rabbit
anti-rat antibody (gift of Dr. Sorribas); lanes 6 and 7, rat lateral CPs stained
with goat anti-human antibody (Santa Cruz Biotechnology) in the presence and
absence of blocking antigen, respectively.
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Perspectives. Because of the role of Pi in vital cellular
activities, perturbation of [Pi]CSF may have notable physiolog-
ical consequences, such as energy stress, an important patho-
genic consequence in many neurodegenerative diseases (19).
Low [Pi] can cause membrane fragility and central nervous
system dysfunction (18), whereas high [Pi] in the extracellular
fluid can stimulate an increased expression of PiT1 and PiT2,
which may be related to increased calcium phosphate deposi-
tion in soft tissues (38), including the basal ganglia, where
mutations in SCL20A2 are linked to disturbed regional phos-
phate homeostasis (Fahr disease) (37). On the other hand, after
excitotoxicity or oxidative stress, high extracellular Pi in-
creases neuronal survival (13). Understanding the mechanisms
responsible for the control of [Pi]CSF could have significance
beyond immediate metabolic status of neurons and glia. The
acid-base buffering capacity of CSF, for example, is minimal,
and at the pH of CSF, Pi is a nearly ideal buffer system;
therefore, keeping [Pi]CSF low may help maintain a high
sensitivity to small shifts in CO2 and [HCO3] in CSF. In
humans, a downward shift of CSF pH by only 0.05 units can
cause a 10-fold increase in breathing rate (27). Another pH-
related implication of regulation by PiT2 is that the H2PO4
substrate availability will be significantly impacted by small
shifts in CSF pH. Whether one considers shark CSF, with a pH
of 7.8 and [Pi] of 0.6 mM, or mammalian CSF, with a pH of
7.2 and [Pi] of 0.4 mM, [H2PO4] is in the range of 50–60
M and is not far from the Pi Km of PiT2 reported for rats (25
M), mice (38 M), and humans (K0.5160 M) (see Ref. 6).
Finally, in vivo experiments in rats have indicated that changes
in [Pi]CSF may have rapid and dramatic effects on renal Pi
excretion and on Pi appetite (21). Thus, the process we describe
here for the removal of CSF Pi may be an important aspect of
Pi, and Ca2, homeostasis. Whereas a specific Ca2-sensing
receptor has been identified, and its roles in the maintenance of
stable systemic Ca2 levels and in hormone secretion have
been well characterized, a similar Pi-sensing mechanism has
not been described. Changes in [Pi] can produce changes in
PiT2 activity that seem to be due to structural changes, not the
amount of PiT2 in the membrane (28). The active state of PiT2
is reported to involve assembly of oligomers in response to
extracellular Pi deprivation. In a bone cell line, this heightened
activity can increase intracellular [Pi] and decrease cAMP (22).
PiT2 activity is also modulated by PKC-ε (17). Thus, choroidal
epithelial PiT2 could be part of a Pi-sensing/regulatory path-
way analogous to the signaling axis proposed for intestinal
phosphate modulation of renal Pi reabsorption (5).
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